HOME >> BIOLOGY >> NEWS
Joslin Diabetes Center launches research section on developmental and stem cell biology

BOSTON -- Joslin Diabetes Center, the global leader in diabetes research, care and education, today announced that it has established a new Section on Developmental and Stem Cell Biology. Research in this field has been ongoing at Joslin for a number of years, particularly in identifying ways to get adult pancreatic cells to grow and produce insulin. The new section will complement Joslin's existing strengths in immunology and islet transplantation research by focusing its research on the potential of developmental biology and stem cells to prevent, halt, and treat diabetes, and its complications.

Joslin also announced that it has recruited two top cell biologists, T. Keith Blackwell, M.D., Ph.D., and Amy Wagers, Ph.D., for the new section, joining long-time Joslin researcher Mary Loeken, Ph.D., who has transferred into the section.

"We're committed to moving stem cell research forward by bringing together top researchers in the field. Drs. Blackwell, Wagers and Loeken are all exceptional and talented scientists. Their combined research can help the Joslin research community continue to lead the way in the important area of stem cell research," says Joslin President C. Ronald Kahn, M.D. "The potential benefits of stem cells on type 1 diabetes make it vital to focus efforts with a new section."

Potential Benefits of Stem Cells

Many scientists believe that stem cell research holds tremendous promise for treating a variety of diseases, including diabetes. There are two basic types of stem cells: those that can multiply to make more copies of themselves ("self-renewing") and give rise to any type of cell in the body, and those that are self-renewing but are capable of yielding only a subset of cell types. Embryonic stem cells, derived from immature cells of the embryo, have the potential to give rise to any type of cell in the body including the insulin-producing beta cells of the pancreas. The viability of islet cell transpla
'"/>

Contact: Marjorie Dwyer
marjorie.dwyer@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
11-Aug-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin researchers clarify mechanisms for beta-cell formation
3. Joslin President awarded medal from international diabetes organization
4. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
5. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
6. Joslin Diabetes Center releases new low impact exercise video
7. Joslin researchers identify key molecule in Type 1 diabetes progression
8. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
9. Diabetes drug may be new tool in treating breast cancer
10. Diabetes in the elderly linked to fewer cellular power plants
11. Diabetes therapies and liquid memory may develop from micro fluid research, Science researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 31, 2019 , ... Molecular ... launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. ... FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering a ...
(Date:7/26/2019)... ANGELES (PRWEB) , ... July 26, 2019 , ... ... to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps to ... trauma. , Helius Medical Technologies is a neurotech company in the ...
(Date:7/23/2019)... , ... July 23, 2019 , ... ... personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded its ... MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded content ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is the market ... Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the ... Market for Point-of-Care (POC) Diagnostics . , Quidel is a market leader in ...
(Date:7/9/2019)... ... 2019 , ... Today, at the BIO World Congress on Industrial ... (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were chosen, ... to produce biobased materials. , “Corn is a sustainable, abundant and affordable ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem ... Meet Biotech. The film focuses on regenerative veterinary medicine as a means of ... recently included in the Brentwood and Pacific Palisades International Film Festival in ...
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
Breaking Biology Technology:
Cached News: